Becton Dickinson and Co. has launched the BD Intevia 1mL two-step disposable autoinjector, a platform device combining autoinjector and pre-fillable syringe in one integrated system. BD Intevia autoinjector is a 2-step push-on-skin device designed to effectively and safely inject a variety of drugs of different viscosities up to 35cP and different fill volumes up to 1mL. The design enables the pharmaceutical industry to adopt it for a variety of drugs without customizing the system components. Optimizing combination products can help avoid problems related to poorly integrated systems – such as breakage and incompatibility – that can occur when components are purchased from multiple suppliers.

Peter Nolan, Worldwide President, BD Medical – Pharmaceutical Systems, said, “BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience. For the patient, the platform technology is designed to promote patient ease of use when self-injecting (2), and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology.”  

BD Intevia 1mL disposable autoinjector design and control point feature enables two-step, push-on-skin activation allowing injection control by the patient. It’s equipped with feedback indicators that visually show patients when the correct dose has been delivered and simultaneously triggers an audible click. These two considerations aim to enable patient treatment adherence.

Nine BD Intevia 1mL disposable autoinjectors studies were conducted on a range of user populations that focused on the device/user interface to identify and eliminate or reduce the risk of use errors. The latest validation study concluded that most participants are willing to use or switch to BD Intevia 1mL disposable autoinjector. Study participants gave high ratings for key product attributes such as overall acceptance and confidence to control start of injection.